LIAISON® XL prevents sample carry over due to adoption of single cavity reaction module (cuvette) and sample tips. Both are in continuous loading and the software monitors the quantity on board. Single-cavity reaction cuvettes can be loaded with any orientation. In each sample are detected Clot and/or risk of insuffi cient Volume by pressure profi le sensor. The high number of cuvettes and sample tips on board allows an high walk away system.
Easy to use with functional icons that help the operator, the LIAISON® XL Software allows the laboratory to achieve a superior level of efficiency and a complete traceability of its activities. The communication between operator and instrument requires neither keyboard nor mouse.
Continuous loading of Sample tube through LIAISON® XL sample racks. Up to 120 sample. Different tube sizes are allowed. Barcode identification recognizes samples.
The loading bay for reagents allows a continuous loading of the LIAISON® XL system with reagents in the form of Integrals or ancillary. The operator will be driven by a led-light in order to optimize the load and unload activities. Up to 25 Integrals and up to 4 ancillary reagents can be used at the same time. The high number of reagents and consumable loaded on board, reduces the operator activities and improves the walk away time. Integrals can be loaded directly in one of the 25 lanes according to the specifications of the LIAISON® XL, multiple of the same Integral can be loaded at the same time if needed. Upon exhaustion of one Integral, the instrument switches automatically to the next inserted reagents, in case of lot consistency LIAISON® XL recognizes position, expiration date and lot number of reagents loaded. All the information is updated automatically during the process.
LIAISON® XL recognizes position and lot number of each bottle of Starter Reagents and upon exhaustion of a starter bottle, it switches automatically to the next inserted bottle, in case of lot consistency. The replacement is in continuous loading and extremely easy due to the “Clip-on” technology. All the information is updated automatically during the process.
Under the reagent area to place tiny items on the table for instant aid to the user (max weight capacity is 2,5 Kg/ 5.5 lbs)
The Cabinet area of LIAISON® XL offers the continuous loading of System Liquid tanks and the continuous unloading of Liquids and Solid waste. The high consumable volumes on board offer a long walk away time.
LIAISON® XL utilizes chemiluminescence technology with magnetic microparticles, the same proven quality technology used for LIAISON®. All the components are ready to use in one Integral. Most of the Integrals, f.e. all the Infectious Disease tests, include the calibrators. The Integral technology with long term of stability on board, improves efficiency and results standardization.
The loading bay for reagents allows a continuous loading of the LIAISON® XL system with reagents in the form of Integrals or ancillary. The operator will be driven by a led-light in order to optimize the load and unload activities. Up to 25 Integrals and up to 4 ancillary reagents can be used at the same time. The high number of reagents and consumable loaded on board, reduces the operator activities and improves the walk away time. Integrals can be loaded directly in one of the 25 lanes according to the specifications of the LIAISON® XL, multiple of the same Integral can be loaded at the same time if needed. Upon exhaustion of one Integral, the instrument switches automatically to the next inserted reagents, in case of lot consistency LIAISON® XL recognizes position, expiration date and lot number of reagents loaded. All the information is updated automatically during the process.
| System description | Random access or batch immunoassay system |
| Throughput | Up to 180 tests per hour |
| Time to first result | 17 minutes - assay dependent |
| Assays on board | 25 |
| Sample racks | 6-mm to 15-mm internal diameter. Up to 100-mm height |
| Sample capacity | 120 samples, 12-position sample racks in a 10-lane sample area |
| Walk-away time | Approximately 6 hours |
| Stat handling | STAT may be assigned to any position in the sample area |
| Sample type | Serum / plasma / urine / CSF |
| Sample integrity control | ? Pneumatic-based level sensor ? Aspirated/dispensed volume detection and flagging ? Clot detection and flagging |
| Sample carryover | Absent due to the use of LIAISON® XL Disposable Tips |
| Sample tubes (all reading types may be active simultaneously) | EAN / Code 128 / Code 39 / Cod-a-bar / Interleaved 2 of 5 |
| Control sera | 2D barcodes recognized by hand-held scanner |
| Reagent cooling | 13°C ± 2°C / 52°F ± 59°F |
| Reagent integrity control | ? Radio Frequency identification (RFID) ? Automatic inventory tracking and updating to integral RFID tag ? Tracking of calibration validity ? Tracking of on-board stability |
| Reagent capacity | 25-position cooled storage for reagent integrals + 4 position cooled storage for reagent ancillaries |
| Cuvettes | On board capacity: up to 1000 |
| Disposable Tips | On board capacity: 576 |
| DI Water | 10-L container + 2-L reservoir |
| Wash Buffer | 10-L container + 2-L reservoir |
| System cleaning solution | 2-L container |
| Solid waste | Up to 2500 Disposable tips and cuvettes |
| Liquid waste | A second container allows an instrument autonomy of 15 min 2 x 10-L containers |
| Loading/unloading of items during system operation | Includes: Sample racks / Reagent integrals / Ancillaries / Cuvettes / Disposable tips / Control racks / Wash liquid / System liquid / Liquid waste / Solid waste / Starter reagents |
| Operating system Monitor | Microsoft® Windows® |
| GUI | 17” diagonal LCD touch sensitive screen ? Quick access to all pages ? Critical events and actions recorded ? Software-guided and logged maintenance |
| Viewing and editing | ? Results available at all times ? Sort, search, filter (display customization available) ? Possibility of evaluation, validation and release of results prior to printing or LIS reporting |
| Retest | Retest always available, even automated based on predefined rules |
| Back-up | Results can be stored manually or automatically |
| Privacy/safety | Compliant with privacy / safety regulations |
| Package | Long-term monitoring including L-J graphs covering Westgard and RiliB?K rules |
| Access | Accessible at all times |
| Rule definitions | Available to users |
| Operating temperature | 15-32°C / 59°F ± 90°F |
| Operating humidity | 10%-85% RH non condensing |
| Electrical | 90-240v, 50-60 Hz |
| Dimensions (excludes monitor and accessories) | Height: 59 in or 150 cm Width: 59 in or 150 cm Depth: 36 in or 90 cm |
| Weight | LIAISON® XL 661 lbs or 300 kg (includes Monitor and Accessories) |
| Noise | 63.9 dBA at operator normal position |
| LIAISON® 25 OH Vitamin D TOTAL | 310600 |
|---|
| Intended Use | For the quantitative determination of 25-OH Vitamin D and other hydroxylated metabolites |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® N-TACT® PTH II Assay | 310660 |
|---|
| Intended Use | For the quantitative determination of human parathyroid hormone |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® 1-84 PTH Assay | 310630 |
|---|
| Intended Use | For the quantitative determination of 1-84 PTH without cross-reaction to 7-84 and other PTH fragments |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® Osteocalcin | 310950 |
|---|
| Intended Use | For the quantitative determination of Osteocalcin |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® BAP OSTASE® | 310970 |
|---|
| Intended Use | For the quantitative determination of Bone Alkaline Phosphatase (BAP). |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® XL 1,25 Dihydroxyvitamin D | 310980 |
|---|
| Intended Use | For the quantitative determination of 1.25 dihydroxyvitamin D (1.25(OH)2 D) in serum, EDTA and Lithium Heparin plasma |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® TSH | 311211 |
|---|
| Intended Use | For the quantitative determination of thyroid-stimulating hormone (TSH) |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® FT3 | 311531 |
|---|
| Intended Use | For the quantitative determination of free triiodothyronine (fT3) |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® FT4 | 311611 |
|---|
| Intended Use | For the quantitative determination of free thyroxine (fT4). |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® T3 | 311311 |
|---|
| Intended Use | For the quantitative determination of total triiodothyronine (T3) |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® T4 | 311411 |
|---|
| Intended Use | For the quantitative determination of total thyroxine (T4) |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® Tg | 311861 |
|---|
| Intended Use | For the quantitative determination of human thyroglobulin (hTg) |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® Anti-Tg | 311711 |
|---|
| Intended Use | For the quantitative determination of autoantibodies against thyroglobulin (Tg) |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® Anti-TPO | 311701 |
|---|
| Intended Use | For the quantitative determination of autoantibodies against thyroid peroxidase (TPO) |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® LH | 312201 |
|---|
| Intended Use | For the quantitative determination of luteinising hormone (LH; lutropin) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® FSH | 312251 |
|---|
| Intended Use | For the quantitative determination of follicle-stimulating hormone (FSH; follitropin) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® Prolactin | 312151 |
|---|
| Intended Use | For the quantitative determination of prolactin |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® Progesterone II Gen | 310690 |
|---|
| Intended Use | For the quantitative determination of progesterone |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® Testosterone | 310410 |
|---|
| Intended Use | For the quantitative determination of testosterone |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® Estradiol II Gen | 310680 |
|---|
| Intended Use | For the quantitative determination of estradiol |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® XL HCG | 312321 |
|---|
| Intended Use | For the quantitative determination of human chorionic gonadotropin (hCG and ?hCG) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® XL HCG | 312321 |
|---|
| Intended Use | For the quantitative determination of human chorionic gonadotropin (hCG and ?hCG) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® Ferritin | 313551 |
|---|
| Intended Use | For the quantitative determination of Ferritin |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® ANA Screen | 310300 |
|---|
| Intended Use | For the collective qualitative determination of autoantibodies directed against the following extractable nuclear antigens (ENA): RNP/Sm, SS-A (Ro), SS-B (La), Scl-70, Jo-1 and centromere (CENP-B), HEp-2, dsDNA |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® dsDNA | 310310 |
|---|
| Intended Use | For the quantitative determination of anti-double-stranded DNA |
| Material provided | Reagent for 100 determinations. |
| LIAISON® tTg IgA | 310320 |
|---|
| Intended Use | For the quantitative determination of IgA autoantibodies against tissue transglutaminase (tTG). |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® ENA Screen | 310330 |
|---|
| Intended Use | For the collective qualitative determination of autoantibodies directed against the following extractable nuclear antigens (ENA): RNP/Sm, SS-A (Ro), SS-B (La), Scl-70, Jo-1 and centromere (CENP-B) |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® Cardiolipin IgG | 310370 |
|---|
| Intended Use | For the semi-quantitative determination of anti-cardiolipin IgG autoantibodies |
| Material provided | Reagent Integral for 50 determinations |
| LIAISON® Cardiolipin IgM | 310380 |
|---|
| Intended Use | For the semi-quantitative determination of anti-cardiolipin IgM autoantibodies |
| Material provided | Reagent Integral for 50 determinations |
| LIAISON® CEA | 314311 |
|---|
| Intended Use | For the quantitative determination of CarcinoEmbryonic Antigen (CEA) |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® fPSA | 314391 |
|---|
| Intended Use | For the quantitative determination of free human Prostate-Specific Antigen (fPSA) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® PSA | 314381 |
|---|
| Intended Use | For quantitative determination of human Prostate-Specific Antigen (PSA) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® CA 15-3 | 314301 |
|---|
| Intended Use | For the quantitative determination of the CA 15-3® antigen (DF3 defined antigen) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® CA 125 II? | 314211 |
|---|
| Intended Use | For the quantitative determination of CA 125 antigen (OC125 defined antigen) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® CA 19-9? | 314171 |
|---|
| Intended Use | For the quantitative determination of the CA 19-9? antigen (1116NS-19-9 defined antigen) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® TPA® -M | 314121 |
|---|
| Intended Use | For the quantitative determination of Tissue Polypeptide Antigen (TPA) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® NSE | 314561 |
|---|
| Intended Use | For the quantitative determination of Neuron-Specific Enolase (NSE) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® S100 | 314701 |
|---|
| Intended Use | For the quantitative determination of Protein S-100 B |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® S100 | 314701 |
|---|
| Intended Use | For the quantitative determination of Protein S-100 B |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® AFP | 314471 |
|---|
| Intended Use | For the quantitative determination of Alpha-FetoProtein (AFP) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® ?2-Microglobulin | 314501 |
|---|
| Intended Use | For the quantitative determination of ?2-Microglobulin |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® Calcitonin II-Gen | 310650 |
|---|
| Intended Use | For the quantitative determination of calcitonin |
| Material provided | Reagent for 100 determinations |
| LIAISON® Direct Renin | 310470 |
|---|
| Intended Use | For the quantitative determination of renin |
| Material provided | Reagent Integral for 100 determinations. |
| LIAISON® ALDOSTERONE | 310450 |
|---|
| Intended Use | For the quantitative determination of Aldosterone |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® ACTH | 313221 |
|---|
| Intended Use | For the quantitative determination of Adrenocorticotropic Hormone |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® Cortisol | 313261 |
|---|
| Intended Use | For the quantitative determination of Cortisol |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® DHEA-S | 310430 |
|---|
| Intended Use | For the quantitative determination of dehydroepiandrosterone sulphate (DHEA-S) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® IGF-I | 313231 |
|---|
| Intended Use | For the quantitative determination of IGF-I (Insulin-like Growth Factor I) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® C-Peptid | 316171 |
|---|
| Intended Use | For the quantitative determination of C-Peptide |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® Insulin | 310360 |
|---|
| Intended Use | For the quantitative determination of Insulin |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® BRAHMS PCT ® II GEN | 318040 |
|---|
| Intended Use | For the quantitative determination of Procalcitonin in human serum and plasma samples. |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® HBsAg | 310100 |
|---|
| Intended Use | For the qualitative determination of Hepatitis B Surface Antigen (HBsAg) Available only on LIAISON® |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® XL murex HBsAg Quant | 310250 |
|---|
| Intended Use | For the quantitative determination of hepatitis B surface antigen (HBsAg) in human serum or plasma samples. Available only on LIAISON® XL |
| Material provided | Reagent integral for 200 determinations. |
| HBsAg Confirmatory Test | 310110 |
|---|
| Intended Use | For confirmation of the presence of Hepatitis B Surface Antigen (HBsAg) in repeatedly reactive samples |
| Material provided | Reagent (anti-HBs + specimen diluent) for 20 determination to be used with LIAISON® HBsAg (310100) and LIAISON® XL MUREX HBsAg Quant (310250). |
| LIAISON® XL murex Anti-HBs | 311220 |
|---|
| Intended Use | For the quantitative determination of antibody to Hepatitis B Surface Antigen (anti-HBs) |
| Material provided | Reagent integral for 200 determinations. |
| LIAISON® XL murex Anti-HBs Plus | 311230 |
|---|
| Intended Use | For the quantitative determination of antibodies to Hepatitis B Surface Antigen (anti-HBs), with additional Specimen Diluent available for dilution of samples > 1000 mIU/mL |
| Material provided | Reagent integral for 200 determinations. |
| LIAISON® Anti-HBc | 310130 |
|---|
| Intended Use | For the qualitative determination of total antibodies to Hepatitis B core Antigen (anti HBc) |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® HBc IgM | 310140 |
|---|
| Intended Use | For the qualitative determination of IgM immunoglobulin to hepatitis B core antigen (IgM anti-HBc) |
| Material provided | Reagent integral for 50 determinations. |
| LIAISON® HBeAg | 310150 |
|---|
| Intended Use | For the quantitative determination of Hepatitis B e Antigen (HBeAg) |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® Anti-HBe | 310160 |
|---|
| Intended Use | For the qualitative determination of antibodies to Hepatitis B e Antigen (HBeAg) |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® anti-HAV | 310170 |
|---|
| Intended Use | For the qualitative determination of total antibodies to Hepatitis A virus (anti-HAV) |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® HAV IgM | 310180 |
|---|
| Intended Use | For the qualitative determination of IgM immunoglobulin to hepatitis A virus (IgM anti-HAV) |
| Material provided | Reagent Integral for 100 determinations |
| LIAISON® XL murex HCV Ab | 310240 |
|---|
| Intended Use | For the qualitative determination of specific antibodies to hepatitis C virus (anti-HCV) in human serum or plasma samples. Available only on LIAISON® XL |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® XL murex HIV Ab/Ag | 310260 |
|---|
| Intended Use | For the combined qualitative determination of p24 antigen of human immunodeficiency virus type 1 (HIV-1) and specific antibodies to both human immunodeficiency virus type 1 (group M and group O) and/or human immunodeficiency virus type 2 (HIV-2). |
| Material provided | Reagent integral for 200 determinations |
| LIAISON® XL murex HIV Ab/Ag HT | 310290 |
|---|
| Intended Use | For the combined qualitative determination of p24 antigen of human immunodeficiency virus type 1 (HIV-1) and specific antibodies to both human immunodeficiency virus type 1 (group M and group O) and/or human immunodeficiency virus type 2 (HIV-2). The LIAISON® XL murex HIV Ab / Ag HT assay is intended to be used as an aid in the diagnosis of HIV-1/HIV-2 infection and as a screening test for donated blood and plasma. |
| Material provided | Reagent integral for 200 determinations |
| Murex HTLV I+II | 8E22-02/96 Wells; 8E22-04/480 Wells |
|---|
| Intended Use | For the qualitative determination of Antibodies to Human T-Lymphotropic Virus types I and II (HTLV-I and HTLV-II). |
| LIAISON® XL murex Chagas | 310280 |
|---|
| Intended Use | For the qualitative determination of antibodies to Trypanosoma cruzi (T. cruzi) in human serum and plasma. The assay is intended to screen individual human donors for the presence of antibodies to T. cruzi or as an aid for the diagnosis of Chagas disease |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® Treponema Screen | 310840 |
|---|
| Intended Use | For the qualitative determination of specific total antibodies to Treponema pallidum |
| Material provided | Reagent Integral for 200 determinations with specimen diluent included |
| LIAISON® EBV IgM | 310500 |
|---|
| Intended Use | For the quantitative determination of IgM antibodies to Epstein-Barr Virus capsid antigens (VCA) |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® VCA IgG | 310510 |
|---|
| Intended Use | For the quantitative determination of IgG antibodies to Epstein-Barr Virus Viral Capsid Antigen (VCA). |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| EBNA IgG | EBVG0580DS/96 Wells |
|---|
| Intended Use | for the qualitative and semi-quantitative determination of IgG class antibodies against Epstein-Barr virus (EBNA) |
| LIAISON® EA IgG | 310540 |
|---|
| Intended Use | For the quantitative determination of IgG antibodies to Epstein-Barr virus Early Antigen (Diffuse) (EA(D)) |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® Toxo IgG II | 310780 |
|---|
| Intended Use | For the quantitative determination of IgG antibodies to Toxoplasma gondii. |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® Toxo IgM | 310710 |
|---|
| Intended Use | For the quantitative determination (antibody capture) of IgM antibodies to Toxoplasma gondii. |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® XL Toxo IgG Avidity | 310795 / 25 tests |
|---|
| Intended Use | For the determination of antigen-binding avidity of IgG antibodies to Toxoplasma gondii |
| LIAISON® Rubella IgG II | 317260 |
|---|
| Intended Use | For the qualitative & quantitative determination of IgG antibodies to Rubella virus. |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® Rubella IgM | 310730 |
|---|
| Intended Use | For the quantitative determination (antibody capture) of IgM antibodies to Rubella virus. |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® CMV IgG II | 310745 / 100 tests |
|---|
| Intended Use | For the quantitative detection of IgG antibodies to Cytomegalovirus |
| LIAISON® CMV IgM II | 310755 / 100 tests |
|---|
| Intended Use | For the quantitative detection of IgM antibodies to Cytomegalovirus |
| LIAISON® CMV IgG Avidity II | 310765 / 25 tests |
|---|
| Intended Use | For the determination of antigen-binding avidity of IgG antibodies to human Cytomegalovirus |
| LIAISON® HSV-1/2 IgG | 310800 |
|---|
| Intended Use | For the qualitative determination of specific IgG antibodies to Herpes simplex 1 virus and Herpes simplex 2 virus |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® HSV-2 IgG | 310810 |
|---|
| Intended Use | For the qualitative determination of specific IgG antibodies to Herpes simplex 2 virus |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® HSV-1/2 IgM | 310820 |
|---|
| Intended Use | For the qualitative determination of specific IgM antibodies to Herpes simplex 1 virus and Herpes simplex 2 virus |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| Parvovirus B19 IgG EIA | V519IG / 96 Wells |
|---|
| Intended Use | For the detection of Parvovirus IgG B19 antibodies |
| Parvovirus B19 IgM EIA | V619IM /96 Wells |
|---|
| Intended Use | For the detection of Parvovirus IgM B19 antibodies |
| Borrelia burgdorferi IgG | BORG0040/96 Wells |
|---|
| Intended Use | For the qualitative and semi-quantitative determination of IgG antibodies against Borrelia burgdorferi. |
| Borrelia burgdorferi IgM | BORM0040/96 Wells |
|---|
| Intended Use | For the qualitative and semi-quantitative determination of IgM antibodies against Borrelia burgdorferi. |
| LIAISON® VZV IgG | 310850 |
|---|
| Intended Use | For the quantitative determination of IgG antibodies to Varicella-Zoster virus |
| Material provided | Reagent Integral for 100 determinations. Diluent included |
| LIAISON® VZV IgM | 310860 |
|---|
| Intended Use | For the qualitative determination of IgM antibodies to Varicella-Zoster virus |
| Material provided | Reagent Integral for 50 determinations. Diluent included |
| LIAISON® Mycoplasma pneumoniae IgG | 317020 / 50 tests |
|---|
| Intended Use | For the semi-quantitative detection of IgG antibodies to Mycoplasma pneumoniae |
| LIAISON® Mycoplasma pneumoniae IgM | 317030 / 50 tests |
|---|
| Intended Use | For the qualitative detection of IgM antibodies to Mycoplasma pneumoniae |
| LIAISON® Measles IgG | 318810 / 100 tests |
|---|
| Intended Use | For the semi-quantitative determination of IgG antibodies to Measles |
| LIAISON® Measles IgM | 318820 / 50 tests |
|---|
| Intended Use | For the quantitative detection of IgM antibodies to Measles |
| LIAISON® Mumps IgG | 318840 / 100 tests |
|---|
| Intended Use | For the semi-quantitative determination of IgG antibodies to Mumps |
| LIAISON® Mumps IgM | 318830 / 50 tests |
|---|
| Intended Use | For the quantitative detection of IgM antibodies to Mumps |
| LIAISON® Chlamydia trachomatis IgG | 310570 |
|---|
| Intended Use | for the semi-quantitative determination of specific IgG antibodies to Chlamydia trachomatis in human serum or plasma samples. The test has to be performed on the LIAISON® analyzer family. |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® Chlamydia trachomatis IgA | 310580 |
|---|
| Intended Use | for the qualitative determination of specific IgA antibodies to Chlamydia trachomatis in human serum or plasma samples. The test has to be performed on the LIAISON® analyzer family. |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® Bordetella pertussis Toxin IgG | 318850 |
|---|
| Intended Use | For the quantitative determination of IgG antibodies to Bordetella pertussis Toxin in human serum and plasma samples. |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® Bordetella pertussis Toxin IgA | 318860 |
|---|
| Intended Use | For the quantitative determination of IgA antibodies to Bordetella pertussis Toxin in human serum and plasma samples. |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® H. pylori IgG | 318980 |
|---|
| Intended Use | For the qualitative determination of IgG antibodies to Helicobacter pylori in human serum |
| Material provided | Reagent integral for 100 determinations. |
| LIAISON® C. difficile GDH | 318910 |
|---|
| Intended Use | For the qualitative detection of GDH antigens. |
| LIAISON® C.difficile toxins A&B | 318900 |
|---|
| Intended Use | For the qualitative detection of Clostridium difficile toxins A and B. |
| LIAISON® H.pylori SA | 318920 |
|---|
| Intended Use | For the qualitative detection of Helicobacter pylori stool antigens. |
| LIAISON® EHEC Toxins 1&2 | 318930 |
|---|
| Intended Use | For the qualitative detection of EHEC toxins 1 and 2. |
| LIAISON® Rotavirus | 318940 |
|---|
| Intended Use | For the qualitative detection of rotavirus stool antigens. |
| LIAISON® Adenovirus | 318950 |
|---|
| Intended Use | The DiaSorin LIAISON®?Adenovirus assay is an?in vitro?diagnostic chemiluminescent immunoassay (CLIA) intended for the qualitative determination of adenovirus antigen in human stool specimens. This test is used primarily as an aid for the diagnosis of acute viral gastroenteritis. Test results are to be used in conjunction with information obtained from the patients’ clinical evaluation and other diagnostic procedures. The assay must be performed on the LIAISON®?Analyzer Family*. |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® Calprotectin | 318960 |
|---|
| Intended Use | The DiaSorin LIAISON®??Calprotectin? Assay is an?in vitro?diagnostic chemiluminescent immunoassay (CLIA) intended for the quantitative measurement, in human stool, of fecal calprotectin, a neutrophilic protein that is a marker of mucosal inflammation. The LIAISON®?Calprotectin Assay can be used as an aid in the diagnosis of inflammatory bowel diseases (IBD), specifically Crohn’s disease and ulcerative colitis, and as an aid in differentiation of IBD from irritable bowel syndrome (IBS). Test results are to be used in conjunction with information obtained from the patients’ clinical evaluation and other diagnostic procedures.? The test has to be performed on the LIAISON®?Analyzer Family*. |
| Material provided | Reagent integral for 100 determinations |
| LIAISON® Campylobacter Ag | 318080 |
|---|
| Intended Use | For the qualitative determination of Campylobacter antigens in stool samples |
| Material provided | Reagent integral for 100 determinations |
BONE & MINERAL
THYROID
REPRODUCTIVE ENDOCRINOLOGY
ANAEMIA
AUTOIMMUNITY
TUMOUR MARKERS
HYPERTENSION
ADRENAL FUNCTION
GROWTH
DIABETES
SEPSIS
VIRAL HEPATITIS AND RETROVIRUSES
CHAGAS
TREPONEMA
EBV
TORCH
BORRELIA
VZV
MYCOPLASMA
MEASLES & MUMPS
CHLAMYDIA
BORDETELLA
H. PYLORI
STOOL DIAGNOSTICS